X
Xiao-Dong Li
Researcher at Shandong University
Publications - 4
Citations - 83
Xiao-Dong Li is an academic researcher from Shandong University. The author has contributed to research in topics: Medicine & Reduction (mathematics). The author has an hindex of 1, co-authored 1 publications receiving 3 citations.
Papers
More filters
Journal ArticleDOI
Rational design of electrocatalytic carbon dioxide reduction for a zero-carbon network.
TL;DR: In this article, the authors present an economic analysis of electrocatalytic CO2 reduction and provide an overview of representative breakthroughs in this field, and point out how theoretical guidelines enable the rational design of high-throughput catalysts and the synergistic promotion of EC reduction performance by optimizing the EC interface and the reactor.
Journal ArticleDOI
Serum positive for the autoantibody against the β(1)-adrenoceptor from Chinese patients with congestive heart failure decreases I(ss) in mouse cardiac myocytes.
Yuan-yuan Wang,Zhi-yong Ma,Zhi-yong Ma,Xiao-Dong Li,Jian-chun Wang,Wei Zhang,Wei Zhang,Li Li,Li Li,Yun Zhang,Yun Zhang +10 more
TL;DR: The electrophysiological recordings indicated that the AAB-β 1 could inhibit I ss in mouse cardiomyocyte in a concentration-dependent manner.
Journal ArticleDOI
The continuous pack-off technology: A novel water-control method and application to offshore horizontal wells of limestone reservoir
TL;DR: In this paper , the authors proposed a novel water-control method which combined particle-filling with inflow control device screens to control the axial annulus flow in a reef limestone reservoir.
Journal ArticleDOI
Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial.
Zhi-Min Zhao,Chuan-wu Zhu,Xiao-Dong Li,Yu-Xi Zhang,Jian-hon Liang,Wei Min Zhang,Yong Zhang,Xianlei Jiang,Yajie Zong,Kai Zhang,Ke-Wei Sun,Biao Zhang,Yun Lv,Huichun Xing,Qing Xie,Ping Liu,Cheng-Hai Liu +16 more
TL;DR: In this paper , the combination of traditional Chinese medicine (TCM) and entecavir was used to regress the liver fibrosis in patients with hepatitis b virus (HBV)-associated advanced fibrosis and experienced anti-viral treatment.